| Literature DB >> 33604535 |
Smriti Patodia1, Alyma Somani1, Maria Thom1.
Abstract
Polyglucosan bodies have been reported in the context of hypoxic-ischaemic perinatal brain injury, mainly in the pallidum but with rare reports in brainstem neurons. We report a case of a five-year-old boy with cerebral palsy and complex neurological features including epilepsy who experienced sudden nocturnal death. At post-mortem long-standing bilateral necrosis of basal ganglia and hippocampal atrophy was identified in keeping with hypoxic-ischaemic perinatal injury. In addition numerous polyglucosan bodies, which were PAS, p62 and ubiquitin positive, were noted in brainstem neurones and dendrites, primarily involving the ventrolateral and dorsomedial medulla. Immunohistochemistry confirmed relative preservation of medullary neuronal populations in the reticular formation, including catecholaminergic (tyrosine hydroxylase, TH), serotonergic (tryptophan hydroxylase) and neurokinin1 receptor/somatostatin positive neurones. The polyglucosan bodies predominated in catecholaminergic neurones which could indicate their selective vulnerability and a functional deficiency, which during a critical peri-ictal period contributed to the sudden unexpected death in epilepsy.Entities:
Keywords: MR, Median raphe; Medulla; PGB, polyglucosan bodies; Polyglucosan bodies; SUDEP; SUDEP, Sudden unexpected death in epilepsy; TH, Tyrosine hydroxylase; TPH, Tryptophan hydroxylase; VLM, Ventrolateral medulla
Year: 2021 PMID: 33604535 PMCID: PMC7875820 DOI: 10.1016/j.ebr.2021.100430
Source DB: PubMed Journal: Epilepsy Behav Rep ISSN: 2589-9864
Immunohistochemistry panel and antibodies used in this study.
| Immunohistochemistry marker | Clone | Dilution |
|---|---|---|
| p62* | P62-BD Transduction: 3/P62LCK Ligand | 1:100 |
| Somatostatin (SST) | Rb H-106, Santacruz Biotechnology | 1:500 |
| Neurokinin1 receptor (NK1R) | S8305, Sigma Aldrich | 1:5000 |
| Tyrosine hydroxylase (TH) | Abcam ab112 | 1: 750 |
| Tryptophan hydroxylase (TPH2) | AB121013, Abcam | 1: 500 |
| Ubiquitin* | Santa Cruz: p4D1 | 1:1200 |
| Zinc transporter 3* | Synaptic Systems: polyclonal | 1:1000 |
*These antibodies were stained using Bond-Max. (Leica Biosystems).
Fig. 1Neuropathology findings in the medulla (examined at obex 6 mm) A. p62 at low power demonstrates the distribution of neuronal inclusions in specific regions of the ventrolateral medulla (VLM, arrow) and in the dorsomedial medulla (arrowhead) in the vicinity of the XIIth cranial nerve nucleus, mainly in axons and process here. In addition, numerous inclusions were present in the external cuneate nucleus (ECu) and solitary tract (ST) nuclei. There were not identified in the median raphe (MR). B. Tyrosine hydroxylase (TH) labelling confirmed preservation and normal distribution of neurones in the VLM, dorsomedial medulla and around the solitary tract. C. Tryptophan hydroxylase (TPH) confirms neurones of normal morphology and distribution mainly in the MR and VLM. D-J. All represent high magnification images of the VLM region. D. H&E revealed numerous basophilic, irregular cytoplasmic inclusions in neuronal perikarya and dendrites. E. These irregular, globular inclusions, distending process were PAS positive in keeping with polyglucosan bodies. A high-resolution version of this slide for use with the Virtual Microscope is available as eSlide: VM06202 F. p62 labelling at lower magnification showed numerous positive structures in the VLM neurones and G. at higher magnification with structures of similar morphology to the PAS stain. H. Inclusions of similar morphology were also evident in many TH labelled neurones but not in TPH2 neurones or in pre-Botzinger neurones, characterised by I. NK1R and J. SST peripheral labelling. Bar approximately equivalent in A, B and C to 2 mm in F to 25 microns and D-J to 50 microns.